Company or ticker...

BioTech

argenx

Argenx is develops new antibody-based medicines to treat serious autoimmune diseases and cancer.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

ARGX

58.3B

11.9

42

11.53%

Key Facts

M. Cap

PS

PE

YTD

58.3B

11.9

42

11.53%

10MA

20MA

50MA

200MA

$ARGX